CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Switzerland's Sonova raises full-year forecasts on market-share gains, product launches

By Reuters News

By Amir Orusov and Anastasiia Kozlova

Nov 12 (Reuters) - Swiss hearing-aid maker Sonova SOON.S on Thursday raised its sales and profit guidance for fiscal 2027, citing gains in market share and solid uptake of new products.

The world's largest maker of hearing aids now expects sales to rise by 6% to 8% in local currency, up from a previous forecast of 5% to 8%, and core operating profit to grow 10% to 13%, compared with an earlier outlook of 7% to 10%, in the year through March 2027.

The upgrade comes as demand across the hearing-aid industry remains robust and provides an early indication of the commercial success of Sonova's AI-powered Phonak EON platform, seen as a key driver of its medium-term growth targets.

"EON is already contributing above our expectations," CEO Eric Bernard said in a statement, adding that the rollout of the platform across markets had supported both growth and market-share gains.

Rival Demant DEMANT.CO raised its full-year guidance for the second time this year in October, helped by stronger growth and a favourable product mix.

Sonova now expects the global hearing-aid market to grow 3% to 5% this year, up from a previous forecast of 2% to 4%.

https://www.reuters.com/graphics/HEARING-STOCK/zjpqlrmravx/chart.png

Investors are also watching Sonova's expansion in Asia-Pacific, which the company sees as a key long-term growth market due to low hearing-aid penetration, ageing populations and rising incomes.

Sales in Asia-Pacific rose 11.4% to 186.9 million francs in the first half of the fiscal year, driven by mid-teens growth in the group's core Hearing Instruments business, particularly in Australia, China and Japan.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.